Funds holding KAIROS PHARMA LTD
ISIN US48301N1046 · United States
- Fund holders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- 170.3K $
- Share of capital
- 1.3 % of 23.7M shares on Aug 12, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 163,934 | 91.6K $ | 0.00 % | 0.69 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 67,944 | 38K $ | 0.29 % | as of Mar 31, 2026 ↗ | |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 59,481 | 36K $ | 0.00 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 7,599 | 4.6K $ | 0.03 % | as of Feb 28, 2026 ↗ | |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 35 | 19.6 $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 5 | +1 | 298,993 | +129.5 % |
| 2026Q1 | 4 | 0 | 130,253 | +33.0 % |
| 2025Q4 | 4 | +1 | 97,955 | +348.5 % |
| 2025Q3 | 3 | +1 | 21,839 | +1,032.1 % |
| 2025Q2 | 2 | 1,929 |
Institutional managers
9 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 111,290 | 62.2K $ | as of Mar 31, 2026 |
| SevenBridge Financial Group, LLC | 44,286 | 30.3K $ | as of Mar 31, 2026 |
| Aptus Capital Advisors, LLC | 44,286 | 24.8K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 39,543 | 22.1K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 24,100 | 13.5K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 21,575 | 12 $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 16,247 | 9.1K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 3,962 | 2.2K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 10 | 6 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding KAIROS PHARMA LTD". https://titelia.com/en/stocks/kairos-pharma-ltd-US48301N1046